Does anyone have a view on the likely duration of this trial?
Are any further details available to the public as you would imagine are contained in the submission to the FDA for its approval?
What are the chances of seeing the interim results (and development milestones) reported directly by AZN or will these first be seen via an SPL announcement?
Ann: Commencement of phase 1 trial for AZD0466 utilising DEP, page-30
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.20M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $29.02K | 281.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 291994 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 72976 | 4 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.5¢ | 10.5¢ | 10.0¢ | 374668 | ||
| Last updated 15.00pm 06/06/2024 ? | |||||
| SPL (ASX) Chart |